RaQualia Pharma Inc.
ラクオリア創薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4579
FY2025 · 2025-12-31
| Gross margin | — |
| Operating margin | — |
| Net margin | — |
| Return on equity | 4.0% |
| Return on assets | 2.6% |
| Revenue growth (YoY) | — |
| EPS (basic) | ¥11.53 |
| EPS growth (YoY) | — |
| Current ratio | 4.46x |
| Equity ratio | 65.6% |
| Book value / share | ¥280 |
| Free cash flow | -422 M |